The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting
Open accessAbstract
BACKGROUND: Metabolomics is the rapidly evolving field of the comprehensive measurement of ideally all endogenous metabolites in a biological fluid. However, no single analytic technique covers the entire spectrum of the human metabolome. Here we present results from a multiplatform study, in which we investigate what kind of results can presently be obtained in the field of diabetes research when combining metabolomics data collected on a complementary set of analytical platforms in the framework of an epidemiological study. METHODOLOGY/PRINCIPAL FINDINGS: 40 individuals with self-reported diabetes and 60 controls (male, over 54 years) were randomly selected from the participants of the population-based KORA (Cooperative Health Research in the Region of Augsburg) study, representing an extensively phenotyped sample of the general German population. Concentrations of over 420 unique small molecules were determined in overnight-fasting blood using three different techniques, covering nuclear magnetic resonance and tandem mass spectrometry. Known biomarkers of diabetes could be replicated by this multiple metabolomic platform approach, including sugar metabolites (1,5-anhydroglucoitol), ketone bodies (3-hydroxybutyrate), and branched chain amino acids. In some cases, diabetes-related medication can be detected (pioglitazone, salicylic acid). CONCLUSIONS/SIGNIFICANCE: Our study depicts the promising potential of metabolomics in diabetes research by identification of a series of known and also novel, deregulated metabolites that associate with diabetes. Key observations include perturbations of metabolic pathways linked to kidney dysfunction (3-indoxyl sulfate), lipid metabolism (glycerophospholipids, free fatty acids), and interaction with the gut microflora (bile acids). Our study suggests that metabolic markers hold the potential to detect diabetes-related complications already under sub-clinical conditions in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 3×
“Table 2 provides metabolites that display significant differences between the case and the control group after controlling for multiple testing using the positive false discovery rate [35] (q-value ,0.”
MethodInfluentialMetabolomics—the link between genotypes and phenotypes
Fiehn, O. (2002) · Plant Molecular Biology · doi:10.1023/a:1013713905833 · Cited by 3,445 · cited 1×
“Metabolomics is the rapidly evolving field of the comprehensive measurement of ideally all endogenous metabolites in a biological fluid [5,6,7,8,9,10].”
BackgroundHMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
Metabolomics — the link between genotypes and phenotypes
Fiehn, O. (2002) · Functional Genomics · doi:10.1007/978-94-010-0448-0_11 · Cited by 3,167
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Metabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Metabolomics--the link between genotypes and phenotypes.
Fiehn, O. (2002) · PubMed · Cited by 1,517
Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009) · Analytical Chemistry · doi:10.1021/ac901536h · Cited by 1,333
The emerging field of lipidomics
Wenk, M. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1776 · Cited by 1,330
Human metabolic phenotype diversity and its association with diet and blood pressure
Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., Ebbels, T., De Iorio, M., Brown, I. J., Veselkov, K. A., et al. (2008) · Nature · doi:10.1038/nature06882 · Cited by 1,054
Dyslipidemia in type 2 diabetes mellitus
Mooradian, A. D. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1066 · Cited by 1,042
Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition Chromatography
Pauling, L., Robinson, A. B., Teranishi, R., & Cary, P. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.10.2374 · Cited by 1,025
The role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974 · cited 1×
“data observed here, this hypothesis is in agreement with the fact that the gut microbiota composition can be different between controls and individuals with diabetes [60].”
ResultTargeted Profiling: Quantitative Analysis of 1H NMR Metabolomics Data
Weljie, A. M., Newton, J., Mercier, P., Carlson, E., & Slupsky, C. M. (2006) · Analytical Chemistry · doi:10.1021/ac060209g · Cited by 900
Large-Scale Human Metabolomics Studies: A Strategy for Data (Pre-) Processing and Validation
Bijlsma, S., Bobeldijk, I., Verheij, E. R., Ramaker, R., Kochhar, S., Macdonald, I. A., van Ommen, B., & Smilde, A. K. (2006) · Analytical Chemistry · doi:10.1021/ac051495j · Cited by 867
Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum
Gieger, C., Geistlinger, L., Altmaier, E., Hrabé de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.-W., Wichmann, H.-E., Weinberger, K. M., Adamski, J., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000282 · Cited by 737
Self-citationGall, W. E., Beebe, K., Lawton, K. A., Adam, K.-P., Mitchell, M. W., Nakhle, P. J., Ryals, J. A., Milburn, M. V., Nannipieri, M., Camastra, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010883 · Cited by 698
Self-citationA genome-wide perspective of genetic variation in human metabolism
Illig, T., Gieger, C., Zhai, G., Römisch-Margl, W., Wang-Sattler, R., Prehn, C., Altmaier, E., Kastenmüller, G., Kato, B. S., Mewes, H.-W., et al. (2010) · Nature Genetics · doi:10.1038/ng.507 · Cited by 653
Self-citationChemometrics in metabolomics—A review in human disease diagnosis
Madsen, R., Lundstedt, T., & Trygg, J. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.11.042 · Cited by 557
Analysis of the Adult Human Plasma Metabolome
Lawton, K. A., Berger, A., Mitchell, M., Milgram, K. E., Evans, A. M., Guo, L., Hanson, R. W., Kalhan, S. C., Ryals, J. A., & Milburn, M. V. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.4.383 · Cited by 490
Self-citationPathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Watson, A. D. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600022-jlr200 · Cited by 455
SLC2A9 influences uric acid concentrations with pronounced sex-specific effects
Döring, A., Gieger, C., Mehta, D., Gohlke, H., Prokisch, H., Coassin, S., Fischer, G., Henke, K., Klopp, N., Kronenberg, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.107 · Cited by 445
Self-citationIndoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
Niwa, T., & Ise, M. (1994) · PubMed · Cited by 440
KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes
Wichmann, H.-E., Gieger, C., & Illig, T. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858226 · Cited by 417
Self-citationThe Role of Leucine in Weight Loss Diets and Glucose Homeostasis
Layman, D. K. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.1.261s · Cited by 385
Wiesner, P., Leidl, K., Boettcher, A., Schmitz, G., & Liebisch, G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.d800028-jlr200 · Cited by 363
Dumas, M.-E., Maibaum, E. C., Teague, C., Ueshima, H., Zhou, B., Lindon, J. C., Nicholson, J. K., Stamler, J., Elliott, P., Chan, Q., et al. (2006) · Analytical Chemistry · doi:10.1021/ac0517085 · Cited by 346
Potential Importance of Leucine in Treatment of Obesity and the Metabolic Syndrome
Layman, D. K., & Walker, D. A. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.1.319s · Cited by 336
Metabolomics Applied to Diabetes Research
Bain, J. R., Stevens, R. D., Wenner, B. R., Ilkayeva, O., Muoio, D. M., & Newgard, C. B. (2009) · Diabetes · doi:10.2337/db09-0580 · Cited by 328
Wollesen, F., Brattström, L., Refsum, H., Ueland, P. M., Berglund, L., & Berne, C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.0550031028.x · Cited by 325
Plasma Acid-Base Patterns in Diabetic Ketoacidosis
Adrogué, H. J., Wilson, H., Boyd, A. E., Suki, W. N., & Eknoyan, G. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212233072603 · Cited by 290
Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes
Lanza, I. R., Zhang, S., Ward, L. E., Karakelides, H., Raftery, D., & Nair, K. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010538 · Cited by 266
Metabonomics in pharmaceutical R & D
Lindon, J. C., Holmes, E., & Nicholson, J. K. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05673.x · Cited by 262
Evidence of different metabolic phenotypes in humans
Assfalg, M., Bertini, I., Colangiuli, D., Luchinat, C., Schäfer, H., Schütz, B., & Spraul, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705685105 · Cited by 258
Crystal Growth Inhibitors for the Prevention of l -Cystine Kidney Stones Through Molecular Design
Rimer, J. D., An, Z., Zhu, Z., Lee, M. H., Goldfarb, D. S., Wesson, J. A., & Ward, M. D. (2010) · Science · doi:10.1126/science.1191968 · Cited by 250
Li, X., Xu, Z., Lu, X., Yang, X., Yin, P., Kong, H., Yu, Y., & Xu, G. (2009) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.11.058 · Cited by 249
Dungan, K. M., Buse, J. B., Largay, J., Kelly, M. M., Button, E. A., Kato, S., & Wittlin, S. (2006) · Diabetes Care · doi:10.2337/dc06-1910 · Cited by 242
Exploring Disease through Metabolomics
Vinayavekhin, N., Homan, E. A., & Saghatelian, A. (2010) · ACS Chemical Biology · doi:10.1021/cb900271r · Cited by 230
Muscle Amino Acid Metabolism and Gluconeogenesis
Ruderman, N. B. (1975) · Annual Review of Medicine · doi:10.1146/annurev.me.26.020175.001333 · Cited by 210
Serum 1,5-Anhydroglucitol (GlycoMark™): A Short-Term Glycemic Marker
Buse, J. B., Freeman, J. L. R., Edelman, S. V., Jovanovic, L., & McGill, J. B. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503765691839 · Cited by 187
The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus
Fujimoto, W. Y. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00337-5 · Cited by 183
McGill, J. B., Cole, T. G., Nowatzke, W., Houghton, S., Ammirati, E. B., Gautille, T., & Sarno, M. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1859 · Cited by 158
Griffin, J. L. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1734 · Cited by 158
Norlund, L., GRUBB, A. O., Fex, G. A., Leksell, H., Nilsson, J.-E., von Schenck, H., & Hultberg, B. L. (1998) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1998.032 · Cited by 156
Dumas, M., Wilder, S. P., Bihoreau, M., Barton, R. H., Fearnside, J., Argoud, K., D’Amato, L., Wallis, R. H., Blancher, C., Keun, H. C., et al. (2007) · Nature Genetics · doi:10.1038/ng2026 · Cited by 151
Metabolic basis of obesity and noninsulin‐dependent diabetes mellitus
Golay, A., Jp, F., Jéquier, E., DeFronzo, R. A., & Ferrannini, E. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040803 · Cited by 145
Niwa, T. (1996) · PubMed · Cited by 140
Griffin, J. L., & Nicholls, A. W. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.7.1095 · Cited by 137
A thematic review series: systems biology approaches to metabolic and cardiovascular disorders
Lusis, A. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.e600004-jlr200 · Cited by 136
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression
Jankowski, J., van der Giet, M., Jankowski, V., Schmidt, S. C., Hemeier, M., Mahn, B., Giebing, G., Tölle, M., Luftmann, H., Schlüter, H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15524 · Cited by 134
Altmaier, E., Ramsay, S. L., Graber, A., Mewes, H., Weinberger, K. M., & Suhre, K. (2008) · Endocrinology · doi:10.1210/en.2007-1747 · Cited by 127
Self-citationHolmes, E. C., Loo, R. L., Cloarec, O., Coen, M., Tang, H., Maibaum, E., Bruce, S., Chan, Q. M., Elliott, P., Stamler, J., et al. (2007) · Analytical Chemistry · doi:10.1021/ac062305n · Cited by 124
Wang‐Sattler, R., Yu, Y., Mittelstraß, K., Lattka, E., Altmaier, E., Gieger, C., Ladwig, K., Dahmen, N., Weinberger, K. M., Hao, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003863 · Cited by 121
Self-citationAltmaier, E., Kastenmüller, G., Römisch‐Margl, W., Thorand, B., Weinberger, K. M., Adamski, J., Illig, T., Döring, A., & Suhre, K. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900116 · Cited by 63
Self-citationFibrinogen, Fibrin and the Arterial Wall
Smith, E. B. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_a.11 · Cited by 59
Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases
R�schinger, W., Olgem�ller, B., Fingerhut, R., Liebl, B., & Roscher, A. A. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1356-y · Cited by 43
Vannini, P., Marchesini, G., Forlani, G., Angiolini, A., Ciavarella, A., Zoli, M., & Pisi, E. (1982) · Diabetologia · doi:10.1007/bf00283757 · Cited by 40
Plasma and Skeletal Muscle Free Amino Acids in Type I, Insulin-treated Diabetic Subjects
Borghi, L., Lugari, R., Montanari, A., Dall'Argine, P., Elia, G., Nicolotti, V., Simoni, I., Parmeggiani, A., Novarini, A., & GNUDI, A. (1985) · Diabetes · doi:10.2337/diab.34.8.812 · Cited by 36
Cited by
Large-scale association analyses identify host factors influencing human gut microbiome composition
Kurilshikov, A., Medina-Gomez, C., Bacigalupe, R., Radjabzadeh, D., Wang, J., Demirkan, A., Le Roy, C. I., Raygoza Garay, J. A., Finnicum, C. T., Liu, X., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00763-1 · Cited by 1,786
Branched-chain amino acids in metabolic signalling and insulin resistance
Lynch, C. J., & Adams, S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.171 · Cited by 1,461
Human metabolic individuality in biomedical and pharmaceutical research
CARDIoGRAM, Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., et al. (2011) · Nature · doi:10.1038/nature10354 · Cited by 1,017
Self-citationFloegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988
Self-citationMetabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
Guasch-Ferré, M., Hruby, A., Toledo, E., Clish, C. B., Martínez-González, M. A., Salas-Salvadó, J., & Hu, F. B. (2016) · Diabetes Care · doi:10.2337/dc15-2251 · Cited by 905
Metadata
- Authors
- Suhre, K., Meisinger, C., Döring, A., Altmaier, E., Belcredi, P., Gieger, C., Chang, D., Milburn, M. V., Gall, W. E., Weinberger, K. M., Mewes, H.-W., Hrabé de Angelis, M., Wichmann, H.-E., Kronenberg, F., Adamski, J., & Illig, T.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-11-11
- Volume
- 5
- Issue
- 11
- Pages
- e13953
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1973529232
- Cited by
- 556
- References
- 59
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.